Multi-Site Reproducibility Study of 3D High-Content Analysis with Dual-View Oblique Plane Microscopy
Yuriy Alexandrov, Mar Arias-GarcíaiD, Chris BakaliD, Eduard BatlleiD, Vicky BousgouniiD, Neil O. CarragheriD, Julien ColombelliiD, Jayne CulleyiD, Nathan CurryiD, Lucas DentiD, Christopher W. DunsbyiD, Liuba DvinskikhiD, Edwin Garcia, Nikolaos-Nikiforos GiakoumakisiD, Nils GustafssoniD, Montserrat LlansesiD, Martin Lee, Kanad N. MandkeiD, Daniel MarksiD, Iain A. McNeishiD, Colin D.H. RatcliffeiD, Erik A. SahaiiD, Hugh SparksiD, Theresa SuckertiD
Abstract
High content imaging is being applied to achieve quantitative fluorescence readouts in increasingly complex 3-dimensional (3D) cell culture models such as spheroids and organoids. Compared to conventional 2D assays, 3D assays better represent biological heterogeneity but require more complex sample preparation, 3D imaging and 3D image analysis that can affect the accuracy and precision of such assays. We used spheroids formed from the NRAS-activated melanoma cell line 19161 modified to express an ERK kinase translocation reporter (KTR) as an exemplar 3D phenotypic assay carried out in 96-well plates. The spheroids were treated with the ERK activator TPA and a range of concentrations of the MEK inhibitor Binimetinib. 3D live-cell imaging with sub-cellular spatial resolution was performed using a dual-view oblique plane microscope (dOPM) - a form of single-objective light-sheet microscope - and the experiment was performed separately at 4 different institutes. The results were analysed using an identical 3D analysis pipeline and parameters. We assessed the variation in assay readout using a linear mixed effects model. Random variance at the well level was negligible (SD = 0.0048 relative to range of KTR biosensor readout at reference site of 0.17), indicating low technical noise. Treatment effects were dose-dependent and highly statistically significant compared to DMSO control across all sites (Dunnett-corrected p < 0.001). The range in KTR readout between the minimum (3.5 M Binimetinib) and maximum (100 nM TPA) treatments varied between 59 to 96% relative to the reference site. Measured bias in KTR readout between sites was between 6 and 12% of the range of the reference site. This study quantifies the reproducibility of a 3D live spheroid-based assay employing a fluorescence biosensor requiring readout out at the per-cell level using the dOPM platform and discusses areas where experimental protocol could be improved in the future to further improve reproducibility.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments
V. Siruvallur Murali, B.-J. Chang, … E. Welf·bioRxiv·Feb 27, 2019
- Microfluidic Live-Imaging technology to perform research activities in 3D models
A. M. Capuzzo, D. Vigo·bioRxiv·Mar 8, 2021
- Multi-site assessment of reproducibility in high-content live cell imaging data
J. Hu, X. Serra-Picamal, … S. Stromblad·bioRxiv·Nov 18, 2022
- A simple, inexpensive and multi scale 3D fluorescent test sample for optical sectioning microscopies
I. Olevsko Arad, K. Szederkenyi, … A. Salomon·bioRxiv·Apr 27, 2021
- What Can We Count On? Performance of Microplate Cell Counting Assays in 2D Monolayer and 3D ECM-based In Vitro Tumour Models
Mahsa Vaezzadeh, Annemarie Nadort, … Anna Guller·bioRxiv·Apr 30, 2026
- Precise, high-throughput production of multicellular spheroids with a bespoke 3D bioprinter
R. H. Utama, L. Atapattu, … J. Gooding·bioRxiv·Apr 6, 2020